Sifting the literature for real-world challenges thwarting adoption of clinical AI across medicine, a team of biomedical engineers and computer scientists has identified and fleshed out an exemplary use case.

Also, Butterfly Network building a new headquarters, Hyperfine names a CEO, and ImaginAb raises $12.8 million in funding. 

Forty-seven percent of presenters and moderators at the society’s 2018 conference who received industry payments didn’t disclose at least one exceeding $200, a new analysis shows.

Dave Scott brings 25 years of knowledge to the Guilford, Connecticut, portable MRI firm, including research and development experience within Apple's secretive Special Projects Group.

Adopting inclusive leadership roles may help the male-dominated specialty move away from bias, experts wrote in Academic Radiology. 

Alzheimer's patients will need to have a brain scan showing the presence of beta-amyloid in order to receive Biogen's Aduhelm (aducanumab) treatment, yet Medicare doesn't cover such exams.

The Food and Drug Administration has approved a new drug that claims to slow the progression of Alzheimer’s disease. The drug is the first approved for Alzheimer’s disease since 2003.

The vast majority of healthcare executives say digital transformation across their organizations is accelerating, according to a recent survey of 399 executives from six countries.

Doc groups believe the title change is "clearly an attempt" to move the PA profession toward independent practice. 

People who wore a mask or face covering and practiced social distancing were less likely to get sick with COVID-19.